September 11, 2017

ProterixBio presents COPD clinical study results at the European Respiratory Society International Congress

Billerica MA, September 12, 2017 – ProterixBio, Inc. today announced that results from a recent clinical study of subjects with chronic obstructive pulmonary disease (COPD) were presented this week at the European Respiratory Society International Congress. Algorithms based on combinations of protein biomarkers were successfully associated with measures of COPD disease activity such as shortness… Read more »

September 9, 2017

ProterixBio presenting COPD clinical study results at the European Respiratory Society International Congress

  ProterixBio, Inc will present clinical study results at the European Respiratory Society International Congress, to be held in Milan, Italy, September 9-13th, 2017. The European Respiratory Society (ERS) is the leading professional organization for respiratory medicine in Europe, publishing academic journals and monographs as well as hosting events aimed at educating health professionals. The… Read more »

January 9, 2017

ProterixBio speaking at Biotech Showcase™ 2017

  ProterixBio, Inc. will be attending Biotech Showcase™ 2017, to be held January 9-11th at the Hilton San Francisco Union Square. Biotech Showcase™ 2017 is one of the industry’s largest annual healthcare investor and partnering conferences, with more than 300 company presentations and 2,800+ attendees expected. Attendees include biopharmaceutical and life science company executives, investors… Read more »